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MATERIALS AND METHODS

Patient Selection
We examined the data obtained from all patients referred to our pulmonary function laboratory from May 1984 to November 1985 for evaluation of arterial blood gas (ABG) changes during exercise. All patients with a resting PaO2 of 8.65 kPa (65 mm Hg) or less and concomitant measurement of SaO by cutaneous oximetry were included. If a patient had more than one study conducted during this period, only results from the first study were included.
Blood Gas and Ear Oximetry Measurements
In each study, ABG samples were drawn (within 5 s) into heparinized 3-ml syringes, immediately placed into ice, and analyzed as soon as possible. Samples were collected with the patient in the upright seated position breathing room air for at least ten minutes. They were analyzed in duplicate for pH, carbon dioxide tension (Pco0), and oxygen tension (PO2) using IL-813 and IL-513 (Instrumentation Laboratories, Lexington, MA) blood gas analyzers. Routine quality control of these measures includes the use of tonometered blood at least once every eight hours and one-point gas calibration checks before each determination.5 In our laboratory, the routine quality control data from using blood tonometered to a P02 of 6.67 kPa (50 mm Hg) indicate that the inaccuracy (observed minus target value) of single measurements of Po2 is 0.093 ± 0.067 kPa (0.7 ± 0.5 mm Hg) (mean ± 1.0 SD). The SaO2, carboxyhemoglobin (COHb), and methemoglobin (MetHb) were measured using a four-wavelength spectrophotometer (IL-282 CO-oximeter, Instrumentation Laboratories). The ABG sample. Both instruments were used following the manufacturer's recommendations. Prior to attaching the Hewlett-Packard ear probe, the ear pinna was massaged with an alcohol pad for 30 to 60 s. Ear perfusion was then checked with a Hewlett-Packard perfusion indicator to ensure adequate perfusion (indicator Xs2 percent error). The ear probe was then attached and secured with the cover provided and by wrapping the head with a gauze bandage. A similar procedure was used to attach the Biox ear oximeter probe. The probe was attached to the pinna with either the manufacturer's retainer or by tape and a headband. The instrument was used in the "fast" response mode, and the calibration was checked before each study using the "test" switch. Measurernents made when the oximeter indicated "low perfusion" were excluded. [Fig 1, bottom] 
RESULTS
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DISCUSSION
The results of this study demonstrate that greater than 80 percent of patients with chronic lung disease who would qualify for ambulatory oxygen supplementation under the current Medicare criteria for resting PaO2 (7.33 kPa [55 mm Hg] or less) would not qualify for such therapy on the basis of a simultaneous SaO2 measured by cutaneous oximetry (85 percent or less). Changing the current Medicare criteria to include a more appropriate threshold criterion of 88 percent SaO2, instead of85 percent, would reduce the number Cutaneous Oximetry (Carlin, Clausen, Ries) I of patients denied this therapy using cutaneous oximetry measurements. However, a small number of patients who would not qualify based on a PaO2 measurement would then qualify based upon a cutaneous SaO2 measurement less than 88 percent.
Cutaneous oximetry offers a rapid, noninvasive, and portable means for the estimation of arterial oxyhemoglobin saturation.45 The HP 47201A (no longer in production) uses an eight-wavelength method in this determination, while newer oximeters, such as the Biox IIA, use a two-wavelength method associated with arterial pulsation. By comparing the absorbance of transmitted light before and during arterial pulsation, absorbance due to arterial oxyhemoglobin can be separated from static background absorbance attributable to skin pigmentation, soft tissue components, and venous blood. 10 Recent studies, however, have demonstrated some limitations of cutaneous oximeters. For SaO2 values greater than 70 percent, the absolute inaccuracy (95 percent confidence limits) of the cutaneous measurement of SaO2 when compared with direct measurement of SaO2 is + 4.0 to 5.0 percent; for SaO2 values less than 70 percent, the error may be appreciably larger. For monitoring changes in SaO2, the inaccuracy is ± 3.0 percent. [4] [5] [6] [7] [8] [9] Invalid measurements can also occur in conditions which result in decreased cutaneous blood flow, or elevated bilirubin, MetHb, or COHb levels. 
